Aclaris Therapeutics, Inc. (ACRS)
6.18
+0.16
(+2.66%)
USD |
NASDAQ |
Sep 02, 16:00
6.09
-0.09
(-1.46%)
After-Hours: 20:00
Aclaris Therapeutics Total Return Level : 6.18 for Sept. 2, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 02, 2026 | 6.18 |
| September 01, 2026 | 6.02 |
| August 31, 2026 | 6.05 |
| August 28, 2026 | 6.01 |
| August 27, 2026 | 6.16 |
| August 26, 2026 | 6.19 |
| August 25, 2026 | 6.535 |
| August 24, 2026 | 6.31 |
| August 21, 2026 | 6.41 |
| August 20, 2026 | 6.33 |
| August 19, 2026 | 6.44 |
| August 18, 2026 | 6.305 |
| August 17, 2026 | 5.92 |
| August 14, 2026 | 5.78 |
| August 13, 2026 | 5.86 |
| August 12, 2026 | 5.84 |
| August 11, 2026 | 5.92 |
| August 10, 2026 | 5.90 |
| August 07, 2026 | 5.91 |
| August 06, 2026 | 6.09 |
| August 05, 2026 | 6.36 |
| August 04, 2026 | 5.98 |
| August 03, 2026 | 5.53 |
| July 31, 2026 | 5.20 |
| July 30, 2026 | 5.32 |
| Date | Value |
|---|---|
| July 29, 2026 | 5.12 |
| July 28, 2026 | 5.33 |
| July 27, 2026 | 5.37 |
| July 24, 2026 | 5.23 |
| July 23, 2026 | 5.48 |
| July 22, 2026 | 5.62 |
| July 21, 2026 | 5.69 |
| July 20, 2026 | 5.57 |
| July 17, 2026 | 5.68 |
| July 16, 2026 | 5.36 |
| July 15, 2026 | 5.60 |
| July 14, 2026 | 5.43 |
| July 13, 2026 | 5.50 |
| July 10, 2026 | 5.58 |
| July 09, 2026 | 5.71 |
| July 08, 2026 | 5.51 |
| July 07, 2026 | 5.62 |
| July 06, 2026 | 5.49 |
| July 02, 2026 | 5.56 |
| July 01, 2026 | 5.34 |
| June 30, 2026 | 5.29 |
| June 29, 2026 | 5.02 |
| June 26, 2026 | 5.00 |
| June 25, 2026 | 4.91 |
| June 24, 2026 | 4.79 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Corcept Therapeutics, Inc. | 110.43 |
| Nektar Therapeutics | 72.74 |
| Xeris Biopharma Holdings, Inc. | 8.58 |
| Crinetics Pharmaceuticals, Inc. | 84.95 |
| Alumis, Inc. | 10.35 |